However, in this state, the biological effect of glucagon is weakened, and the impact of glucagon on SIRT1 is also impaired, while SIRT1 can inhibit hepatic steatosis and inflammatory responses to hepatic metabolic disorders. This evidence concerns the gene SIRT1 and Hepatic steatosis.